Abstract Details
|
Michal Szulc
PRESENTER |
No disclosure on file |
| Kiren Kresa-Reahl, MD (Atara Biotherapeutics) | Dr. Kresa-Reahl has received personal compensation for serving as an employee of Atara Biotherapeutics Inc.. Dr. Kresa-Reahl has received stock or an ownership interest from Atara Biotherapeutics Inc. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Wojciech Kozubski | No disclosure on file |
| No disclosure on file |